| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Ubenimex | 1580RB; NK-421; NSC-265489 | Approved | Nippon Kayaku | Bestatin | Japan | Leukemia, Lymphoid | s:4:"null"; | 1987-01-01 | Leukemia, Lymphoid; Lymphedema; Pulmonary Arterial Hypertension | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Acebilustat | EP-501; CTX-4430 | Phase 2 Clinical | Celtaxsys | Cystic Fibrosis | Details |
This web search service is supported by Google Inc.
A-Z